NewsRx

Search our medical news database

Glaucoma

IOptima Receives CE Approval of its IOPtiMateTM Laser System for Treatment of Glaucoma

Published in Medical Device Business Week, August 26th, 2009

IOptima of the Israeli Based Bio-Light group (TASE: BOLT) announces that it has received CE approval for its OT-134 Laser based system, known also as IOPtiMateTM , for the non invasive filtration treatment of Glaucoma.

IOPtima, a leading Israeli based company focused in the development and commercialization of advanced technologies for Glaucoma treatment, developed a novel CO2 laser based system (IOPtiMate TM) which enables the performance of a swift simplified, efficient and cost effective filtration procedure for the alleviation of Intra Ocular Pressure. The IOPtiMate TM is a breakthrough technology which enables practitioners to provide a safe and efficient...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Device Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook